Celularity (CELUW) Cash from Financing Activities (2019 - 2025)
Celularity (CELUW) reported Cash from Financing Activities of $11.2 million for Q4 2025, up 1644.95% year-over-year from $643000.0 in Q4 2024, and up 222.6% quarter-over-quarter from $3.5 million in Q3 2025.
Celularity (CELUW) Cash from Financing Activities (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Cash from Financing Activities data on file, last reported at $11.2 million in Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $11.2 million, up 1644.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $18.6 million (up 178.3% YoY), and the FY2025 annual result was $18.6 million, up 178.3% from the prior year.
- Cash from Financing Activities advanced to $11.2 million in Q4 2025 per CELUW's latest filing, from $3.5 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $100.4 million in Q3 2021 and troughed at -$4.8 million in Q1 2021.
- A 5-year average of $13.4 million and a median of $3.7 million in 2021 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2021 and 2024: Cash from Financing Activities tumbled 219.87% in 2021, then surged 4692.86% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$1.0 million in 2021, then soared by 266.17% to $1.7 million in 2022, then sank by 100.83% to -$14000.0 in 2023, then surged by 4692.86% to $643000.0 in 2024, then soared by 1644.95% to $11.2 million in 2025.
- Business Quant data shows CELUW's Cash from Financing Activities at $11.2 million in Q4 2025, $3.5 million in Q3 2025, and $1.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | Celularity | - | - | -3.27 Mn | 11.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.22 Mn |
| Dec 31, 2025 | 11.22 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 643,000.00 |
| Dec 31, 2024 | 643,000.00 |
| Sep 30, 2024 | -79,000.00 |
| Sep 30, 2024 | -79,000.00 |
| Jun 30, 2024 | -90,000.00 |
| Jun 30, 2024 | -90,000.00 |
| Mar 31, 2024 | 6.23 Mn |
| Mar 31, 2024 | 6.23 Mn |
| Dec 31, 2023 | -14,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | 5.74 Mn |
| Sep 30, 2023 | 5.74 Mn |